Filing Details
- Accession Number:
- 0001140361-10-047282
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-29 11:49:49
- Reporting Period:
- 2010-11-24
- Filing Date:
- 2010-11-29
- Accepted Time:
- 2010-11-29 11:49:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377232 | Phd J Michael Williams | One Idexx Drive Westbrook ME 04092 | Corporate Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-11-24 | 2,661 | $65.16 | 9,078 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $65.15 to $65.201, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Includes 64 shares and 75 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 6/30/2010 and 9/30/2010, respectively.
Billionaire Hedge Funds
